The store will not work correctly when cookies are disabled.
4-methyl-N-(2,2,2-trichloro-1-(4-nitrophenylthio)ethyl)benzamide
ID: ALA1086589
Cas Number: 302902-25-6
PubChem CID: 3093506
Max Phase: Preclinical
Molecular Formula: C16H13Cl3N2O3S
Molecular Weight: 419.72
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(=O)NC(Sc2ccc([N+](=O)[O-])cc2)C(Cl)(Cl)Cl)cc1
Standard InChI: InChI=1S/C16H13Cl3N2O3S/c1-10-2-4-11(5-3-10)14(22)20-15(16(17,18)19)25-13-8-6-12(7-9-13)21(23)24/h2-9,15H,1H3,(H,20,22)
Standard InChI Key: XFAKQJSOOQVAHX-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 26 0 0 0 0 0 0 0 0999 V2000
0.1444 -25.7708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1432 -26.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8581 -27.0110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5745 -26.5977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5716 -25.7672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8563 -25.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5716 -27.0101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2857 -26.5970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5722 -27.8351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.0005 -27.0090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7146 -26.5959 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.0011 -27.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7159 -28.2459 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-1.2870 -28.2470 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-2.0083 -28.6583 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-3.4294 -27.0078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1412 -26.5975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8519 -27.0087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8508 -27.8346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1366 -28.2475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4270 -27.8339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2846 -25.3520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.5668 -28.2445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.5665 -29.0696 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.2853 -27.8323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6 1 1 0
12 13 1 0
1 2 2 0
12 14 1 0
2 7 1 0
12 15 1 0
3 4 2 0
11 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
7 9 2 0
18 19 2 0
4 5 1 0
19 20 1 0
8 10 1 0
20 21 2 0
21 16 1 0
2 3 1 0
5 22 1 0
10 11 1 0
5 6 2 0
10 12 1 0
23 24 2 0
23 25 1 0
19 23 1 0
M CHG 2 23 1 25 -1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 419.72 | Molecular Weight (Monoisotopic): 417.9712 | AlogP: 5.12 | #Rotatable Bonds: 5 |
Polar Surface Area: 72.24 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.44 | CX LogD: 5.44 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.24 | Np Likeness Score: -1.38 |
References
1. Baraldi PG, Preti D, Materazzi S, Geppetti P.. (2010) Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents., 53 (14): [PMID:20356305] [10.1021/jm100062h] |